Skip to main content
Erschienen in: Trials 1/2020

Open Access 22.06.2020 | COVID-19 | Letter

AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial

verfasst von: Gareth Griffiths, Richard Fitzgerald, Thomas Jaki, Andrea Corkhill, Ellice Marwood, Helen Reynolds, Louise Stanton, Sean Ewings, Susannah Condie, Emma Wrixon, Andrea Norton, Mike Radford, Sara Yeats, Jane Robertson, Rachel Darby-Dowman, Lauren Walker, Saye Khoo, on behalf of the UK NIHR community

Erschienen in: Trials | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial
verfasst von
Gareth Griffiths
Richard Fitzgerald
Thomas Jaki
Andrea Corkhill
Ellice Marwood
Helen Reynolds
Louise Stanton
Sean Ewings
Susannah Condie
Emma Wrixon
Andrea Norton
Mike Radford
Sara Yeats
Jane Robertson
Rachel Darby-Dowman
Lauren Walker
Saye Khoo
on behalf of the UK NIHR community
Publikationsdatum
22.06.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04473-1

Weitere Artikel der Ausgabe 1/2020

Trials 1/2020 Zur Ausgabe